Hydroxichloroquine for COVID-19 infection: Do we have a final word after one year?


Posted: 2021-11-09 20:00:00
Eur J Intern Med . 2021 Oct 26;S0953-6205(21)00366-6. doi: 10.1016/j.ejim.2021.10.026. Online ahead of print. Affiliations Expand Affiliations 1 Mediterranea Cardiocentro, Napoli, Italy. Electronic address: dicastel@ngi.it. 2 Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell'Elettronica, Pozzilli, Isernia 86077, Italy. 3 Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell'Elettronica, Pozzilli, Isernia 86077, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy. Item in Clipboard Augusto Di Castelnuovo et al. Eur J Intern Med. 2021. Show details Display options Display options Format Eur J Intern Med . 2021 Oct 26;S0953-6205(21)00366-6. doi: 10.1016/j.ejim.2021.10.026. Online ahead of print. Affiliations 1 Mediterranea Cardiocentro, Napoli, Italy. Electronic address: dicastel@ngi.it. 2 Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell'Elettronica, Pozzilli, Isernia 86077, Italy. 3 Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell'Elettronica, Pozzilli, Isernia 86077, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy. Item in Clipboard CiteDisplay options Display options Format Abstract The results presently available from randomised clinical trials and their meta-analysis indicate that Hydroxychloroquine is not associated in COVID-19 patients with either decreased mortality or clinical worsening. Thus, the use of Hydroxychloroquine in COVID-19 patients cannot at present be encouraged. However, the hypothesis that Hydroxychloroquine might have a beneficial role in subgroups of patients at low risk and/or when used at low dosage (≤ 400 mg/day) deserves to be tested in large, well designed randomised clinical trials. Keywords: COVID-19; Hydroxychloroquine; Infectious disease; Mortality; SARS-CoV-2. Copyright © 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. [x] Cite Copy Format: Send To [x]

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
5月 20, 2020 バイオアソシエイツ

温度や緯度はCOVID-19の感染拡大と関連しておらず、学校の閉鎖、身体的離隔、公衆衛生対策はプラスの効果をもたらすことがカナダの研究で判明

2020年5月8日にCMAJ(Canadian Medical Association Journal)でオンライン公開された多国間の調査によると、気温と緯度は新型コロナウイルス( COVID-19 )の蔓延とは関連していないようだ。しかし学校の閉鎖やその他の公衆衛生対策がプラスの効果をもたらしているという。 この論文は「COVID-19パンデミックに対する気候と公衆衛生の介入の影響:前向きコホート研究(Impact of climate and public health interventions on…

ゲスト 587人 と メンバー 6人 がオンラインです